SYBX
Price:
$0.74
Market Cap:
$8.66M
Operating as a clinical-stage biopharmaceutical enterprise, Synlogic, Inc. is dedicated to the creation and progression of synthetic biotic therapeutics aimed at addressing metabolic and immunological conditions across the United States. Its robust portfolio features multiple drug candidates: SYNB1618 and SYNB1934, both non-systemically absorbed and orally administered, are progressing through Phase II clinical trials for phenylketonuria. Another oral, non-systemic agent, SYNB1353, is designed to treat homocystinuria. Furthermore, SYNB8802, an orally taken, non-systemic compound, is currently in Phase I trials for managing enteric hyperoxaluria. Beyond oral treatments, the company is also de...[Read more]
Industry
Biotechnology
IPO Date
2015-09-30
Stock Exchange
NASDAQ
Ticker
SYBX
According to Synlogic, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -5449486.00. This represents a change of 470.27% compared to the average of -955591.22 of the last 4 quarters.
The mean historical Enterprise Value of Synlogic, Inc. over the last ten years is 104.02M. The current -5449486.00 Enterprise Value has changed -623.87% with respect to the historical average. Over the past ten years (40 quarters), SYBX's Enterprise Value was at its highest in in the September 2018 quarter at 337.49M. The Enterprise Value was at its lowest in in the March 2026 quarter at -6544103.68.
Average
104.02M
Median
63.33M
Minimum
-20905040.50
Maximum
547.14M
Discovering the peaks and valleys of Synlogic, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 133.59%
Maximum Annual Enterprise Value = 547.14M
Minimum Annual Increase = -849.30%
Minimum Annual Enterprise Value = -20905040.50
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -878661.92 | -50.78% |
| 2024 | -1785307.40 | -109.73% |
| 2023 | 18.35M | -68.87% |
| 2022 | 58.95M | -57.30% |
| 2021 | 138.05M | 103.91% |
| 2020 | 67.70M | -12.03% |
| 2019 | 76.96M | -50.87% |
| 2018 | 156.64M | -849.30% |
| 2017 | -20905040.50 | -103.82% |
| 2016 | 547.14M | 133.59% |
The current Enterprise Value of Synlogic, Inc. (SYBX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.23M
5-year avg
42.54M
10-year avg
104.02M
Synlogic, Inc.’s Enterprise Value is less than Lixte Biotechnology Holdings, Inc. (69.65M), less than Allarity Therapeutics, Inc. (24.44M), less than Lexaria Bioscience Corp. (7.53M), less than Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (11.03M), less than Cingulate Inc. (8.89M), greater than Curis, Inc. (-8118049.00), less than Entero Therapeutics, Inc. (19.92M), less than Kairos Pharma, Ltd. (5.75M), less than BriaCell Therapeutics Corp. (-1763599.79), less than Processa Pharmaceuticals, Inc. (3.23M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 69.65M | $71.84M | |
| 24.44M | $22.75M | |
| 7.53M | $12.56M | |
| 11.03M | $10.64M | |
| 8.89M | $27.36M | |
| -8118049.00 | $5.55M | |
| 19.92M | $13.58M | |
| 5.75M | $9.42M | |
| -1763599.79 | $5.22M | |
| 3.23M | $4.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synlogic, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synlogic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Synlogic, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Synlogic, Inc. (SYBX)?
What is the 3-year average Enterprise Value for Synlogic, Inc. (SYBX)?
What is the 5-year average Enterprise Value for Synlogic, Inc. (SYBX)?
How does the current Enterprise Value for Synlogic, Inc. (SYBX) compare to its historical average?